Literature DB >> 9013814

Distribution of thyrotropin-releasing hormone (TRH) receptors in the brain of the ataxic mutant mouse, rolling mouse Nagoya.

K Kinoshita1, M Yamamura, J Sugihara.   

Abstract

Thyrotropin-releasing hormone (TRH) and its analog, TA-0910, ameliorate the ataxia of the mutant mouse, rolling mouse Nagoya, by metabolic normalization in the ventral tegmental field (VTF). We here investigated the distribution of cerebral TRH receptors in the rolling mouse to clarify the sites of action of these drugs. TRH receptors were widely distributed in multiple brain areas, including in the VTF and the cuneiform nucleus (CnF) which terminates in the VTF. These results suggest that TRH and TA-0910 directly activate the VTF by acting on TRH receptors in the VTF and indirectly activate it through the receptors in the CnF.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9013814     DOI: 10.1248/bpb.20.86

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  2 in total

1.  Thyrotropin-releasing hormone receptor type 1 (TRH-R1), not TRH-R2, primarily mediates taltirelin actions in the CNS of mice.

Authors:  Nanthakumar Thirunarayanan; Eshel A Nir; Bruce M Raaka; Marvin C Gershengorn
Journal:  Neuropsychopharmacology       Date:  2012-12-11       Impact factor: 7.853

2.  Taltirelin is a superagonist at the human thyrotropin-releasing hormone receptor.

Authors:  Nanthakumar Thirunarayanan; Bruce M Raaka; Marvin C Gershengorn
Journal:  Front Endocrinol (Lausanne)       Date:  2012-10-09       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.